MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 56 filers reported holding MERSANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $119,000 | -35.3% | 29,837 | +0.8% | 0.00% | – |
| Q4 2021 | $184,000 | -42.0% | 29,586 | -11.9% | 0.00% | – |
| Q3 2021 | $317,000 | -35.2% | 33,572 | -6.7% | 0.00% | – |
| Q2 2021 | $489,000 | -24.1% | 35,986 | -9.6% | 0.00% | – |
| Q1 2021 | $644,000 | +5.9% | 39,801 | +74.2% | 0.00% | – |
| Q4 2020 | $608,000 | +64.3% | 22,850 | +15.1% | 0.00% | – |
| Q3 2020 | $370,000 | -20.6% | 19,860 | -0.3% | 0.00% | – |
| Q2 2020 | $466,000 | +448.2% | 19,915 | +36.3% | 0.00% | – |
| Q1 2020 | $85,000 | +11.8% | 14,611 | +9.5% | 0.00% | – |
| Q4 2019 | $76,000 | -17.4% | 13,348 | -77.1% | 0.00% | – |
| Q3 2019 | $92,000 | -81.5% | 58,237 | -52.6% | 0.00% | – |
| Q2 2019 | $498,000 | -19.4% | 122,873 | +4.6% | 0.00% | -100.0% |
| Q1 2019 | $618,000 | +30.9% | 117,514 | +1.7% | 0.00% | – |
| Q4 2018 | $472,000 | -26.9% | 115,574 | +78.8% | 0.00% | -100.0% |
| Q3 2018 | $646,000 | -17.9% | 64,626 | +46.6% | 0.00% | 0.0% |
| Q2 2018 | $787,000 | +42.6% | 44,088 | +26.0% | 0.00% | 0.0% |
| Q1 2018 | $552,000 | +42.6% | 34,984 | +48.5% | 0.00% | – |
| Q4 2017 | $387,000 | -4.9% | 23,555 | +0.2% | 0.00% | – |
| Q3 2017 | $407,000 | – | 23,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |